GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (MEX:GRAL) » Definitions » ROCE %

GRAIL (MEX:GRAL) ROCE % : -24.53% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. GRAIL's annualized ROCE % for the quarter that ended in Sep. 2024 was -24.53%.


GRAIL ROCE % Historical Data

The historical data trend for GRAIL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL ROCE % Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23
ROCE %
-46.92 -41.62 -27.63 -17.20

GRAIL Quarterly Data
Dec18 Jun19 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -20.76 -21.55 -23.87 -24.53

GRAIL ROCE % Calculation

GRAIL's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-13527.05/( ( (96270.975 - 2630.81) + (66434.049 - 2777.157) )/ 2 )
=-13527.05/( (93640.165+63656.892)/ 2 )
=-13527.05/78648.5285
=-17.20 %

GRAIL's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=-14453.232/( ( (59900.142 - 1615.43) + (61393.45 - 1856.165) )/ 2 )
=-14453.232/( ( 58284.712 + 59537.285 )/ 2 )
=-14453.232/58910.9985
=-24.53 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GRAIL  (MEX:GRAL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


GRAIL ROCE % Related Terms

Thank you for viewing the detailed overview of GRAIL's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


GRAIL Business Description

Comparable Companies
Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.